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Abstract
Background. There is consistent evidence that theory of mind (ToM) is impaired in schizo-
phrenia (SZ); however, it remains unclear whether such deficits are trait- or state-dependent.We
evaluated ToM in patients with schizophrenia spectrum disorders (SSDs), their healthy first-
degree relatives, and controls to test its suitability as an endophenotypic marker.We also studied
the modifying effect of markers of clinical and genetic liability to SZ (schizotypy and genetic
variability in the oxytocin receptor gene: OXTR) on ToM in healthy individuals.
Methods. The sample included 38 stable SSD patients, 80 unaffected first-degree relatives, and
81 controls. ToM was assessed using the Hinting Task (HT) and schizotypy via the Schizotypal
Personality Questionnaire-Brief (SPQ-B), which generates interpersonal (SPQ-IP), cognitive-
perceptual (SPQ-CP), and disorganization (SPQ-D) scores. The polymorphism rs53576 of
OXTR was genotyped.
Results. Patients presented poorer HT performance than relatives and controls (p = 0.003 and
p < 0.001). High SPQ-IP and SPQ-CP scores correlated with poorer ToM performance in
relatives (p = 0.010 and p= 0.030), but not in controls. OXTR was not associated with HT
scores, but it showed amodifying effect within controls; high SPQ-CPwas related toHT poorer
performance conditional to GG genotype (p = 0.007).
Conclusions. ToM deficits were present in patients but not in unaffected relatives or controls.
However, our data indicate the usefulness of clinical and genetic liability markers to characterize
differences in ToM abilities within healthy individuals. Then, the observed link between ToM
and SZ liability suggests the putative role of ToM as an endophenotypic marker. Nevertheless,
new analyses in larger samples are needed.
Introduction
Schizophrenia (SZ) is a prevalent and severe psychiatric disorder with a complex etiology
involving environmental and genetic factors (heritability ffi 80%). The high degree of disability,
prevalence, chronicity, and financial costs place an enormous burden on patients with SZ, their
families, and society as a whole. This burden warrants efforts to identify predictors directly
applicable to prevention, diagnosis, and therapy. Research into these predictors has produced
growing evidence that social cognition deficits are an important predictor of outcome, evenmore
so than neurocognition [1]. Social cognition refers to a wide range of skills that allow people to
perceive, interpret and process social stimuli, and that guide social interactions. One of its
multiple components is theory of mind (ToM), that is, the ability to infer mental states, such
as beliefs, intentions, desires, and emotions, in other people [2].
ToM impairments are being increasingly reported in SZ [3–5]. Although some studies have
interpreted ToM deficits as a state marker associated with symptoms in the active phase of the
disease [6] or with the severity of negative symptoms [7], the majority have reported ToM
impairment to be a trait marker, still present in remission [8,9] and found to be stable after a
longitudinal 3-year follow-up design [10]. Several studies also indicate that ToM deficits are present
in first-episode psychosis and in high-risk individuals (unmedicated prodromal subjects) [4,11].
Family-based study designs are suitable for establishing whether ToM is a trait feature when
the defect is also seen in healthy family members (in a higher prevalence than in controls).
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the advantage of controlling for certain confounder factors, as
family members have a shared genetic background and tend to be
more homogeneous with respect to exposure to environmental
factors.
Meta-analytic data on social cognition in unaffected relatives of
patients with SZ have reported their decreased performance when
compared to healthy controls [12] and that the social cognition
abilities in relatives lie somewhere between the levels seen in
probands and in healthy non-relatives [4].
All of the above, in addition to the fact that some social cognitive
impairment are heritable (28–37% for emotion recognition) [13],
account for the interest in social cognition as a candidate endophe-
notype.
To explain the heterogeneous results in the relative group and to
detect healthy relatives with a potentially higher genetic loading for
SZ, a useful strategy would be to study the association between the
endophenotypic marker and other known vulnerability markers in
SZ such as schizotypy, family history, and specific genetic factors.
Schizotypy is a set of personality traits that encompasses behaviors,
cognitions, and emotions, and resembles the signs and symptoms of
SZ in the general population. It has been associated with ToM
impairment [14,15].
As regards the biological underpinnings of ToM, the most
extensively studied neuropeptide to date is oxytocin (OXT). On
the one hand, several functional neuroimaging studies have shown
that OXT has significant modulatory effects on “social brain,”
which refers to the brain systems that govern social cognition, social
behavior, and affect regulation [16]. For example, acute OXT
administration in healthy subjects has been shown to modulate
amygdala activity as well as other regions (e.g., prefrontal areas,
superior temporal sulcus, and fusiform gyrus) and to enhance the
functional connectivity of the amygdala with other brain regions
[17,18]. Also, animal models of psychosis have shown that OXT
administration reduces dopaminergic hyperactivity in the striatum
and nucleus accumbens [19] in a similar manner to antipsychotic
medications [20,21].
On the other hand, some studies in healthy subjects have shown
the enhancing effect of intranasal OXT administration on social
cognition [22] and specifically on ToM [23] and that this is an age-
independent effect [24]. A meta-analysis based on neurodevelop-
mental disorders (SZ and autism spectrum disorders) also reported
the age-independent intranasal OXT improvement effect on ToM
across these disorders [23]. Accordingly, it has been suggested that
both the anatomy and functional physiology of the human nervous
system may be shaped by OXT signaling pathways (and their
interaction with dopaminergic ones), leading to the idea that their
variability may contribute to individual differences in social
behavior and cognition by modulating the neural circuits involved
in processing socio-affective information [25,26].
Importantly, the behavioral effects of OXT depend on the
distribution and expression of its receptor (OXTR). OXT receptors
are present in numerous limbic and reward-related regions of the
human brain; mainly in (but not restricted to) the amygdala, the
hippocampus and the nucleus accumbens, and also in cortical
regions (such as the anterior cingulate cortex) [27]. The receptor
is coded by the OXTR gene and its polymorphic variability
may contribute to individual differences in social behavior and
cognition [25].
General population-based studies have highlighted the influence
of this gene on many facets of social cognition including ToM. The
most intensively examined single nucleotide polymorphism (SNP)
in OXTR is rs53576, and a recent meta-analysis showed that
individuals with a greater number of G alleles present better
empathic ability [28]. Interestingly, Rodrigues et al. [29] linked the
lower empathy exhibited byA allele carriers of this SNPwith a higher
physiological stress reactivity as compared to GG individuals.
Furthermore,OXTR polymorphic variants (rs53576 and others)
have been associated with the risk for SZ and with other neurode-
velopmental disorders (reviewed in [17]).
Neuroimaging studies have provided evidence to support the
rs53576 association with brain structure and activity, mainly in
healthy subjects. For instance, Tost et al. [30] described that A
allele carriers of rs53576 show the lowest amygdala activation and
an increased coupling of the hypothalamus and the amygdala
when processing social information. Data also suggest that
rs53576 influences striatal dopamine availability and modulates
the interactions between the oxytocinergic and dopaminergic
systems. In a study based on single-photon emission-computed
tomography (SPECT), striatal dopamine transporter availability
in G carriers (AG/GG) was lower than in the AA group, and G
carriers showed a negative correlation between dopamine trans-
porter availability and OXT level [31]. Then, despite rs53576 is a
silent polymorphism and that the pathophysiological significance
of its association with brain phenotypes remains to be elucidated,
accumulated evidence suggest that this SNP could be a marker of
the role of the OXTR in the neural mechanism that links the
differences in the oxytocinergic system to individual differences
in social cognition.
In line with the above, our study first aimed to explore ToM in
schizophrenia-spectrum disorder (SSD) patients, healthy first-
degree relatives, and healthy controls to test whether ToM deficits
may be a putative endophenotypic marker of SZ. We hypothesized
that ToM deficits would show a trait marker pattern with first-
degree relatives showing intermediate scores between patients and
healthy controls. Second, to understand the ToM variability, we
aimed to investigate whether ToM is modified by: (i) clinical
liability to SZ in healthy individuals (schizotypy) and (ii) the
OXT receptor gene (OXTR). We hypothesized that the polymor-
phism rs53576 at the OXTR would modify the association between
schizotypy and ToM, and that the allelic variants would
co-segregate with ToM performance within families.
Methods
Sample
The sample comprised 199 individuals: 38 patients with a diagnosis
of a SSD, 80 healthy first-degree relatives of these patients
(22 fathers, 30 mothers, and 28 siblings), and 81 unrelated controls
with no psychiatric history (Table 1). All participants were of
Caucasian origin. All were recruited at the Centre de Salut Mental
d’Adults de Lleida and evaluated by the same clinician (S.M.), and
were assessed when they were clinically stable.
Patients’DSM-IV-TR diagnoses were: SZ (n=32) and psychotic
disorder not otherwise specified (n=6). Patients’mean age at onset
was 22.12 (SD=3.83) and the mean duration of illness was 26.40
months (SD=24.44).
All patients were treated with antipsychotic monotherapy:
94.7% with second-generation antipsychotic (24 risperidone,
5 olanzapine, 3 amisulpride, 2 ziprasidone, 2 clozapine) and 5.3%
with haloperidol.
The exclusion criteria for relatives included any psychotic spec-
trum disorder and any major affective disorder. Controls had no
personal or family history of psychiatric disorders or treatment.
2 Maria Giralt-López et al.
Other exclusion criteria common to all groups were any major
medical illness that could affect brain function, neurological con-
ditions, and history of head trauma with loss of consciousness.
All participants provided written consent after being informed
of the study procedures and implications. The study was performed
in accordance with the guidelines of the institutions involved and
approved by the local research ethics committees. All procedures
were carried out in accordance with the latest version of the
Declaration of Helsinki.
Assessments
The patients were diagnosed according to DSM-IV-TR criteria and
interviewed by means of the Comprehensive Assessment of Symp-
toms and History [32].
Symptom severity and prevalence of positive or negative symp-
toms were assessed by means of The Positive and Negative Syn-
drome Scale (PANSS) [33]. It is a 30-item scale designed to obtain a
measure of positive, negative, and general psychopathology symp-
toms in patients with SZ. The scores for these scales are arrived at by
summation of ratings across component items. In addition to these
measures, a Composite Scale is scored by subtracting the negative
score from the positive score. This yields a bipolar index, which is
essentially a difference score reflecting the degree of predominance
of one syndrome (positive or negative) in relation to the other.
Based on the previously reported association between insight
and social cognition [34], the PANSS item “lack of insight”was also
independently used to test such association.
Social cognition, specifically ToM, was assessed by means of the
Spanish version of the Hinting Task (HT) [35,36], a test that
consists of 10 brief stories involving two people in a conversation.
The task is to infer what a person is implying indirectly. In each
item, a correct answer gives 2 points (for a total of 20 points). In case
of an incorrect answer, an additional hint is given, after which a
correct answer gives 1 point.
The task has good validity for patients with SZ and has proven
sensitive to ToM difficulties in a number of studies to date [37].
Schizotypy assessment was carried out by means of the Schizo-
typal Personality Questionnaire-Brief (SPQ-B) [38]. SPQ-B is a
22-item self-report; each item presents a statement or question to
the respondent, who then circles “yes” or “no.” Each affirmative
response counts as one point toward the total score, which ranges
from 0 to 22, with higher scores indicating higher levels of self-
reported schizotypy. Itemswere created tomeasure three schizotypal
dimensions: cognitive-perceptual dimension (i.e., ideas of reference
or odd beliefs), interpersonal dimension (i.e., suspiciousness, inap-
propriate, or constricted affect), and disorganization dimension
(i.e., odd thinking/speech/behavior/appearance). In order to select
a subgroup of carriers of higher-vulnerability SPQ subscales, raw
scores were dichotomized using the SPSS visual binning method in
each group to define high/low scorers for each SPQ subscale.
Intellectual quotient (IQ) was estimated using the Block Design
and Vocabulary or Information WAIS-III subtests.
Family historywas assessedwith the Family Interview forGenetic
Studies. Following broad SZ spectrum criteria [39], families were
classified as having a positive family history when patients had at
least one first- or second-degree relative with SZ, affective or non-
affective psychosis, or schizotypal or paranoid personality disorder.
Molecular analysis
Genomic DNA was extracted from peripheral blood cells or buccal
mucosa using standard methods, that is, the Real Extraction DNA
Kit (Durviz S.L.U., Valencia, Spain) or the BuccalAmp DNA
Extraction Kit (Epicenter Biotechnologies, Madison, WI).
The OXTR gene on chromosome 3p25 spans ~19kbp and con-
tains four exons and three introns. Genotyping of the intronic SNP
rs53576 in theOXTR genewas performed using a fluorescence-based
allelic discrimination procedure (TaqMan 50 exonuclease assays;
Applied Biosystems). Standard conditions were observed. The gen-
otyping call rate was higher than 86%. After randomly regenotyping
10% of the sample, 100% of the genotyping results were confirmed.
The SNP was in Hardy–Weinberg equilibrium. Due to the low
frequency of individuals homozygous for the allele A, the genotype
variable was dichotomized in GG versus A allele carriers (AA+AG).
Statistical analyses
All data were processed using SPSS 22.0 software (SPSS IBM,
Armonk, NY).
Sociodemographic and clinical data were compared between
groups by means of analysis of variance (ANOVA) tests or a chi-
squared test when appropriate.
The effect of age, years spent in education, and IQ on HT
performance for each group was tested using the Pearson correla-
tion test. Within groups, differences on HT performance according
to sex or family history were tested using Student’s t-test. From all
these analyses, age and sex showed a trend toward or significant
effect in relatives (p=0.059 and p=0.001, respectively), so they
were added as covariates in the subsequent analyses.
Table 1. Sample description and statistical comparisons among patients, first-degree relatives, and controls
Patients (n = 38) First-degree relatives (n = 80) Controls (n = 81) ANOVA F/χ2 (p) Post hoc significant differences
Male (%) 73.68 41.25 45.68 11.54 (0.003) P >C, P >R
Age at interview 24.92 (3.90) 44.74 (13.43) 34.77 (12.53) 38.46 (<0.001) R >C>P
Years of education 13.43 (3.12) 11.42 (4.83) 15.23 (3.82) 16.59 (<0.001) C >R, P >R
IQ 90.03 (15.23) 94.97 (15.26) 107.98 (11.96) 27.67 (<0.001) C >R, C >P
PANSS positive 10.63 (3.36) – –
PANSS negative 20.37 (4.01) – –
PANSS general 32.58 (7.32) – –
PANSS “lack of insight” 2.50 (0.80) – –
Proportion (%) or mean scores (SD). Only significant differences in post hoc comparisons are given (all p-values were <0.001).
Abbreviations: C, controls; P, patients; R, first-degree relatives.
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The association between HT performance and clinical charac-
teristics (PANSS) within patients was tested with linear regressions
(adjusted for age and sex).
HT performance differences between patients and their first-
degree relatives were assessed by means of linear mixed models
(LMMs) with total HT as the dependent variable, family member
(patients/first-degree relative) as the fixed-effect factor, sex and age
as fixed-effect covariates, and family as the random effect (subjects
nested within families). When the analyses included nonrelated
groups (patients vs. controls and relatives vs. controls), the same
models were used for the comparison without including the family
random effect.
The association between HT performance and schizotypy
within healthy relatives and controls was tested with linear regres-
sion (adjusted for age, sex, and family history).
To test the putative effect of theOXTR gene as a mediator of the
relationship between HT performance and schizotypy, the geno-
type (GG vs. A allele carriers) was added to these analyses.
In addition, a family-based association test between rs53576 and
the HT scores was conducted with PLINK v1.07 by means of the
quantitative transmission disequilibrium test (qTDT). Since
PLINK does not allow covariates to be included in qTDT analyses,
the analyses were performed in two steps. First, lineal regressions
between HT scores and each schizotypy factor (covaried by age and
sex) were conducted. Second, the residuals from these regressions
were used to conduct the qTDT.
Results
Sample characteristics
Tables 1 and 2 show the main sociodemographic and clinical data of
the sample. The proportion ofmales was higher in the patients group
(73.7% male) than in the relatives (41.3%) or controls (45.7%)
groups. Relatives had spent less time in education than patients or
controls. Such a difference was mainly attributable to parents (mean
years of education [SD]=9.46 (4.05) and not to siblings (mean years
of education [SD]=14.93 (4.12)]. IQs were higher in the control
sample than in the relatives or patients. A total of 21.1% of patients
and 17.5% of relatives had a family history of psychotic disorders.
Within the family group, there were no significant differences in
HT or SPQ-B scores between siblings and parents (data not shown);
for this reason, they were considered a single group in all analyses.
According to the PANSS Composite Scale, all patients showed
more prevalent negative than positive symptoms. When we tested
whether ToM performance in patients is modulated by clinical
severity or insight as measured with PANSS, no association was
detected. Thus, these clinical variables were not considered in the
following analyses.
Analysis of ToM performance in SSD patients relative to their
first-degree relatives and healthy individuals
A comparison of HT performance between patients and first-degree
relatives and between patients and controls showed significant group
effects (F =8.96, p =0.003 and F =17.64, p<0.001, respectively).
Patients presented lower scores than relatives (estimated mean dif-
ference=2.27) and controls (estimated mean difference =2.44).
These results remained significant after including IQ as a covariate
(p =0.007 and p =0.025, respectively). The scores of relatives and
controls did not differ significantly.
Association between HT performance and schizotypy in healthy
relatives and controls
We tested whether ToM performance in healthy individuals is
modulated by schizotypy, a marker of liability to SSD.
A linear regression analysis (adjusted for age, sex, and family
history) showed that being a high scorer for Schizotypal Personality
Questionnaire-interpersonal (SPQ-IP; β=0.277, p =0.010, Radj2 =
22.2%) and Schizotypal Personality Questionnaire cognitive-
perceptual (SPQ-CP; β =0.243, p=0.030, Radj2 = 20%) was related
to poorer ToM performance in relatives. Results for SPQ-IP
remained significant when the IQ was included as a covariate (p =
0.025). No such relationship was observed in the controls.
Association betweenOXTR gene (rs53576) and ToMperformance
For the OXTR SNP, the genotype distribution is shown in Table 3.
The qTDT analysis showed no association between the OXTR
gene and HT performance within families.
The rs53576 (GG vs. A allele carriers) did not show a significant
association with HT performance but showed a modifying effect on
the relationship between schizotypy and HT in controls. When
including the OXTR variability in the model (see “Association
between Hinting Task performance and schizotypy in healthy
relatives and controls” section) being a high scorer for SPQ-CP
turned to be related to poorer ToM performance in controls
(β =0.307, p =0.030, Radj2 = 13.8%). Accordingly, within GG
subjects (17 SPQ-CP low scorers and 12 high scorers), the effect of
SPQ-CPonHTperformancewas statistically significant (β=0.468,
p =0.007, Radj
2 = 30.1%), while it was not within A carriers.
Table 2. ToM and schizotypy (SPQ-B) scores in patients (P), their first-degree relatives (R), and controls (C)
HTa
Patients First-degree relatives Controls
15.74 (4.07) 17.88 (2.16) 18.46 (1.64)
Low scorers High scorers Low scorers High scorers Low scorers High scorers
SPQ-CPb 0.91 (0.81) 4.15 (1.41) 0 (0) 2.00 (1.11) 0 (0) 2.00 (1.11)
SPQ-IPb 2.38 (1.50) 6.55 (1.13) 1.60 (1.01) 4.96 (1.19) 1.05 (0.83) 4.03 (1.15)
SPQ-Db 0 (0) 2.24 (1.48) 0 (0) 1.63 (0.92) 0 (0) 1.39 (0.72)
Schizotypy scores for each dimension were dichotomized in low and high scorers. Mean scores (SD).
Abbreviations: HT, Hinting Task; SPQ-CP, Schizotypal Personality Questionnaire-cognitive-perceptual; SPQ-D, Schizotypal Personality Questionnaire-disorganization; SPQ-IP, Schizotypal
Personality Questionnaire-interpersonal.
aAvailable for 39 patients, 82 relatives, and 81 controls.
bAvailable for 36 patients, 76 relatives, and 68 controls.
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In relatives, the association between SPQ and HT remained
significant while the genotype did not show an effect per se.
Discussion
In our study, SZpatients showed impairments in inferring themental
states of others (i.e., intentions) via indirect speech such as hints,
measured with the HT, in comparison to controls. This result is
consistent with previous studies that have used the same task [40–42]
and others that have used different tools for assessing ToM [3,5,8,11].
To further investigate the properties of ToM as an endopheno-
typic marker, we looked at how healthy relatives behave in relation
to patients and controls. In our study, the mean score of healthy
relatives in the HT fell somewhere between the scores of the other
two groups, but the differences between relatives and controls were
not significant. In line with our findings, other studies that have
assessed ToM aspects have also observed no differences in relatives
compared to controls [43,44]. In contrast, other studies have sug-
gested a genetic liability effect with relatives demonstrating impair-
ments in advanced ToM ability [4,45,46]. A recent study that
included several different measurements reported mixed results
across tasks [9].
This heterogeneity of results could be explained by different
factors including the sample sizes of studies and the different tasks
used to evaluate ToM.
First-order false belief or deception tasks test the ability to
understand that someone can have an inaccurate mental represen-
tation of events based on incomplete knowledge. In a second-order
false belief or deception task, participants have to infer the (false)
beliefs of one character about the (false) beliefs of a second
character [47,48].
More complex ToM includes the comprehension of indirect
speech, such as irony, metaphors, faux pas, and hints, assessed using
the Strange Stories Task [49] or the HT. This is based on the notion
that understanding indirect speech requires an understanding of
another person’s mental state.
It has been reported that ToM abilities might decline at
different times over the course of SZ. This is consistent with
Brüne’s developmental model, which posits that ToM abilities
decline in the reverse order of acquisition [5]. Therefore, deteri-
oration is first detected in complex ToM tasks, while the decline
in first-order ToM tasks is observed later. This theory is consis-
tent with studies that have observed a deficit in second-order
mentalizing questions, but not in first-order inference items, in
patients experiencing a first episode of psychosis [50]. Thus, it
can be deduced that tasks assessing higher-order forms of ToM
could be more sensitive and especially appropriate for detecting
ToM impairment in nonclinical samples such as healthy relatives.
Also, there could be other factors intrinsic to the task that
conditions its sensitivity to changes in social cognition abilities
performance. For instance, Grainger et al. [24] detected that
intranasal OXT administration improved ToM when the task
had minimal contextual information, but not when the task
had enriched contextual information.
Another element to consider when explaining the heterogeneity
of ToM capacities in the healthy relatives’ group is the variability in
clinically defined liability. As regards to the selection of schizotypy,
it is a clinical liability marker that has shown to be useful in the
identification of families with a higher genetic loading for SZ
[51]. In this respect, our study shows that high levels of positive
and negative schizotypy (cognitive-perceptual and interpersonal
dimensions) are related to poorer ToMperformance in relatives but
not in controls. Within the general population, ToM has been
extensively studied in relation to schizotypy. Several studies have
detected ToM impairments associated with high levels of total
schizotypy [14,15]. In line with our results, other studies have failed
to identify this association in controls [52,53], but some have
reported that poorer social cognition is a function of specific
schizotypy traits such as positive schizotypy [54,55].
Overall, themixed findings associated with schizotypy and ToM
performance in healthy controls may be due to the fact that indi-
viduals with positive and negative schizotypy display poor ToM
performances for different reasons. Frith [56] asserted that indi-
viduals with positive symptoms of SZ show deficits in ToM tasks
due to inaccurate representations of the intentions of others,
whereas individuals with negative symptoms of SZ display ToM
deficits due to a lack of experience of or interest in social interac-
tions. It may also be that different aspects of social cognition are
differentially affected by positive and negative schizotypy.
Another fact that could explain the heterogeneity is the different
ways of quantifying schizotypy levels. Some studies have used a
continuous variable, while others have usedmedian splits or the top
and bottom 5 or 10% in an attempt to emphasize the qualitative
differences between groups. We were not able to use this method
due to the limited size of our sample.
In contrast to the results for the control group, data from the
subgroup of healthy relatives of SZ-spectrum patients suggest that
high levels of cognitive-perceptual and interpersonal dimensions
are related to poorer ToM performance. To the best of our knowl-
edge, only three studies have tested this association in a sample of
healthy relatives of SZ patients. Two found no significant correla-
tions between ToM and schizotypy scores in the relative sample
[57,58]. However, SPQ mean scores and ranges in these samples
were somewhat low.
Irani et al. [59] used the Revised Eyes Test and reported a trend
whereby relatives were more accurate than patients and less accu-
rate than controls in the ToM task, although these differences only
became significant when the SPQ social-interpersonal subscale
scores were included. This is consistent with the hypothesis that
these social-interpersonal features are the best differentiators
between relatives and controls, and might be the most important
schizotypal traits associated with genetic vulnerability for SZ
[60]. Despite the fact that the relatives in our sample showed higher
schizotypy levels than controls on the social-interpersonal subscale,
differences were not significant.
Table 3. Genotype frequencies for the single nucleotide polymorphism rs53576 at the OXTR gene and HT mean scores within each group
Patients (n = 37) Relatives (n = 76) Controls (n = 56)
GG GA AA GG GA AA GG GA AA
Genotype frequencies 21 (56.8%) 15 (40.5%) 1 (2.7%) 43 (56.6%) 31 (40.8%) 2 (2.6%) 31 (55.4%) 21 (37.5%) 4 (7.1%)
HT mean score (SD) 15.24 (4.83) 16.20 (3.03) 16.00 17.77 (2.40) 17.97 (1.96) 19.50 (0.71) 18.58 (1.61) 18.38 (1.80) 18.00 (1.63)
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In our study, schizotypy symptoms in healthy first-degree
relatives seem to put individuals at an increased risk of these
ToM deficits, thus suggesting that some social cognition functions
might be sensitive to subthreshold psychotic symptoms. These
results are similar to those reported by Johnson et al. [61], in which
the relationship between schizotypy and other measures of cogni-
tion was mediated by SZ genetic risk.
Finally, regarding the role of the OXTR gene in ToM, our study
did not report a family-based association. However, despite not
having an effect per se on HT, the genotype showed a modifying
effect of the association between schizotypy and HT in controls.
Then, while the genotype did not change the significant relationship
observed between schizotypy and HT within relatives, in controls,
this association became significant when the polymorphism was
included. This suggests that in controls (with less liability load than
relatives) high schizotypy would be related to a poorer performance
on ToM conditional to GG genotype. This result is consistent with
other studies that observed the role of this polymorphism on differ-
ent social cognition domains in healthy subjects [25–27], nonetheless
the comparison is not straightforward as previous studies were based
on different social cognition dimensions or scales and none has
analyzed the role of OXTR gene jointly with schizotypy. In all, these
results should be treated with caution, as the sample size limits the
statistical power of our study and replication is needed in larger
samples in order to confirm such effect.
Given the well-documented role of OXT in mammalian social
behavior, and the previously mentioned effects of OXT adminis-
tration on social abilities in humans, it is not surprising that OXTR
gene variability has been studied with a range of social phenotypes
[62]. In this regard, some studies have provided evidence that
OXTR polymorphisms are associated with different dimensions
of social cognition in healthy individuals [63,64] and also with
the risk for SZ and poorer performance in ToM measurements in
SZ, while others have failed to find such an association [17,65,66].
Focusing on the family-based approach, despite the design being
particularly robust for controlling widespread confounds such as
admixture and stratification [67], we are aware of only one previous
study with a similar approach as ours. In that study,Wade et al. [67]
reported the association of another polymorphism at intron 3 of
OXTR (rs11131149) with social cognition in 18months old chil-
dren. Interestingly, the same authors also reported the interaction
between OXTR and parenting behavior on 4 years old children’s
ToM [68], suggesting a nature–nurture interaction with regard to
ToM in early development. Therefore, our results add to the
variability and discrepancies observed in the limited body of liter-
ature in relation to SZ, which are likely related to several factors
such as the diversity of genotypes across studies, the variation in
participants’ ancestry and limited sample sizes. Also, for the under-
standing of heterogeneity across studies, our data and other family-
based studies indicate the need of considering environmental and
developmental factors.
To interpret our data, it is important to consider the strengths
and limitations of the study. The strengths include the use of a
family-based design with a control group of healthy subjects and
the availability of social cognition measurements and clinical and
genetic liability markers. In addition, only a few studies have
explored the association between social cognition and schizotypy,
and none of these has incorporated data on genetic liability (family
history and genetic variability). The design of our study and the
phenotypic variability therefore contributes to the state–trait
debate and helps shed light on the heterogeneity of the complex
traits related to SZ liability.
On the other hand, even though the sample size is comparable to
previous studies and that one of the main disadvantages of family-
based designs is the challenge associated with recruiting large
samples of well-characterized families, the size of our sample
represents the main limitation of the study. In line with this, the
family-based design is intrinsically associated with differences in
sample sizes of the subgroups (more relatives than patients), which
could represent a bias when conducting subgroups comparison
analyses. Moreover, although ToM is an important area of social
cognition, other areas, such as emotion processing and social
knowledge, were not studied. Also, according to some recent data
showing that antipsychotic treatment can improve social cognition
performance [69,70], the non-inclusion of the treatment data in our
analyses could limit the interpretation of our results. Then, if we
had excluded the treatment effect, the patients’ performance on
ToM could be potentially worse and could show larger differences
with relatives and healthy controls. Finally, although one of the
most studied polymorphisms in the OXTR gene is rs53576, the
analysis of a single SNP does not represent the whole variability
gamut ofOXTR. In addition, like many human competencies, ToM
is a complex trait influenced by multiple genes, future research
should screen the polymorphic variability along theOXTR gene and
other OXT signaling pathway-related genes.
In conclusion, our study initially shows that ToM deficits are
greater in patients with SSDs as compared to healthy relatives and
controls; however, when clinical and genetic liability markers such
as schizotypy andOXTR gene in healthy subjects are considered, our
data indicate the putative role of ToM as a trait marker. Our study
does not report the role of the polymorphism rs53576 at the OXTR
gene on ToM abilities within families; however, new studies in larger
family-based samples are needed.
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